Search results
Results from the WOW.Com Content Network
In 1956, two British scientists, John Barnes and Peter Magee, reported that a simple member of the large class of N-nitrosamines, dimethylnitrosamine, produced liver tumours in rats. Subsequent studies showed that approximately 90% of the 300 nitrosamines tested were carcinogenic in a wide variety of animals. [15]
Among the tobacco-specific nitrosamines, nicotine-derived nitrosamine ketone (NNK) and N-nitrosonornicotine (NNN) are the most carcinogenic. [1] Others include N ′-nitrosoanatabine (NAT) and N-nitrosoanabasine (NAB). NNK and its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) are potent systemic lung carcinogens in rats ...
Generally, people should not be exposed to a lifetime risk of cancer exceeding 1 in 100,000 from nitrosamines in their medicines. [12] EU regulators first became aware of nitrosamines in medicines in mid-2018, and took regulatory actions, including recalling medicines and stopping the use of active substances from certain manufacturers. [12]
NMOR is in fact used to generate liver cancer models in rats. Along with N -diethylnitrosamine, it is the gold standard for producing hepatocarcinoma with 100% lung metastasis. [ 21 ]
N-Nitrosonornicotine (NNN) is a tobacco-specific nitrosamine produced during the curing and processing of tobacco. NNN from synthesis of nicotine and nitrous acid.
An alternative possible formation of diazonium and carbenium ions is through the enzymatic reaction of nitrosamines. [ 5 ] Typical accompanying symptoms during the medical cancer treatment via N -nitroso ureas are the impairment of bone marrow (damage of the stem cell compartment), lymphatic tissue and the gastrointestinal tract.
Where to shop today's best deals: Kate Spade, Amazon, Walmart and more
This article about an organic compound is a stub. You can help Wikipedia by expanding it.